Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.19
0.17 (16.67%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.84%
After-hours: Aug 15, 2025, 07:57 PM EDT
Lineage Cell Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 42.27M | 47.89M | 45.79M | 27.75M | 29.62M | 43.58M | 35.44M | 31.47M | 33.89M | 15.45M | 11.36M | 24.75M | 70.86M | 78.06M | 55.74M | 60.81M | 62M | 56.21M |
Short-Term Investments | 17K | 19K | 2.02M | 4.96M | 8.87M | 45K | 50K | 9.86M | 12.04M | 31.36M | 46.52M | 41.6M | 1.17M | 1.88M | 2.62M | 4.29M | 6.75M | 6.15M |
Long-Term Investments | n/a | n/a | n/a | n/a | 548K | 546K | 550K | n/a | 562K | 458K | 581K | 545K | 504K | 544K | 535K | 519K | 515K | 506K |
Other Long-Term Assets | 511K | 504K | 614K | 606K | 50K | 50K | 27K | 1.08M | 588K | 635K | 627K | 591K | 598K | 639K | 630K | 614K | 610K | 601K |
Receivables | 256K | 213K | 638K | 405K | 235K | 77K | 745K | 432K | 443K | 203K | 297K | 434K | 707K | 515K | 50.84M | 79K | 326K | 109K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.3M | 1.87M | 2.55M | 1.28M | 1.66M | 2.02M | 2.2M | 1.72M | 2.12M | 2.64M | 1.83M | n/a | 1.29M | 1.41M | n/a | n/a | 2.5M | 2.15M |
Total Current Assets | 43.84M | 49.98M | 51M | 34.4M | 40.39M | 45.72M | 38.44M | 43.48M | 48.49M | 49.66M | 60M | 68.51M | 74.03M | 81.87M | 111.55M | 68.34M | 71.58M | 64.62M |
Property-Plant & Equipment | 4.07M | 4.05M | 4.39M | 4.38M | 4.6M | 4.96M | 4.77M | 4.85M | 5.31M | 5.58M | 5.67M | 4.65M | 3.87M | 4.55M | 4.87M | 4.73M | 5.01M | 5.11M |
Goodwill & Intangibles | 42.37M | 57.21M | 57.21M | 57.21M | 57.21M | 57.21M | 57.23M | 57.27M | 57.3M | 57.33M | 57.36M | 57.4M | 57.43M | 57.46M | 57.49M | 57.53M | 57.56M | 57.59M |
Total Long-Term Assets | 46.95M | 61.77M | 62.22M | 62.19M | 62.41M | 62.77M | 62.58M | 62.67M | 63.2M | 63.55M | 63.66M | 62.64M | 61.9M | 62.65M | 63M | 62.87M | 63.18M | 63.31M |
Total Assets | 90.8M | 111.75M | 113.22M | 96.59M | 102.8M | 108.48M | 101.02M | 106.15M | 111.69M | 113.2M | 123.66M | 131.15M | 135.92M | 144.52M | 174.54M | 131.21M | 134.75M | 127.93M |
Account Payables | n/a | 2M | 1.17M | 1.6M | 2.39M | 2.21M | 2.05M | 2.43M | 2.19M | 3M | 2.39M | 2.87M | 2.59M | 2.96M | 3.54M | 3.46M | 2.72M | 2.8M |
Deferred Revenue | 5.26M | 6.93M | 7.39M | 8.25M | 9.14M | 10.11M | 10.81M | 9.91M | 10.38M | 11.01M | 9.42M | 12.36M | 15.79M | 14.88M | 18.12M | 975K | 613K | 101K |
Short-Term Debt | 1.05M | n/a | n/a | n/a | 1.11M | 1.1M | 882K | 936K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 523K |
Other Current Liabilities | 4.45M | 2.08M | n/a | 2.49M | 1.1M | -110K | 2.24M | -587K | 582K | 442K | 3.83M | 5.03M | 4.5M | 4.42M | 22.46M | 1.9M | 1.29M | 1.17M |
Total Current Liabilities | 10.76M | 13.09M | 13.98M | 13.86M | 15.28M | 16.89M | 17.96M | 15.88M | 16.05M | 17.23M | 18.98M | 22.74M | 25.09M | 24.59M | 47.12M | 8.79M | 6.77M | 6.62M |
Long-Term Debt | 1.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 31.55M | 6.06M | 6.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 4K | 4K | 5K | 30K | 39K | 384K | 418K |
Total Long-Term Liabilities | 32.93M | 21.01M | 22.23M | 17.94M | 20.65M | 20.6M | 21.04M | 23.61M | 24.38M | 26.96M | 32.75M | 30.86M | 29.33M | 34.71M | 36.53M | 2.83M | 4.38M | 4.74M |
Total Liabilities | 43.69M | 34.1M | 36.21M | 31.8M | 35.93M | 37.49M | 39M | 39.49M | 40.43M | 44.19M | 51.73M | 53.59M | 54.42M | 59.3M | 83.65M | 11.62M | 11.15M | 11.36M |
Total Debt | 2.15M | 2.24M | 2.51M | 2.75M | 2.95M | 3.25M | 2.95M | 3.08M | 3.4M | 3.64M | 3.9M | 2.8M | 2.1M | 2.56M | 2.8M | 2.72M | 2.9M | 3.55M |
Common Stock | 490.55M | 489.31M | 484.72M | 469.27M | 467.93M | 466.57M | 451.34M | 450.28M | 448.25M | 441.3M | 440.28M | 439.15M | 437.15M | 435.82M | 434.53M | 432.25M | 428.05M | 415.26M |
Retained Earnings | -438.07M | -407.6M | -403.46M | -400.19M | -397.16M | -391.4M | -384.86M | -380.08M | -372.97M | -367.74M | -363.37M | -357.02M | -350.95M | -344.18M | -337.1M | -308.11M | -300.28M | -295.49M |
Comprehensive Income | -4.1M | -2.68M | -2.88M | -2.89M | -2.47M | -2.77M | -3.07M | -2.08M | -2.61M | -3.11M | -3.57M | -3.18M | -3.36M | -5.09M | -5.21M | -3.43M | -3.05M | -2.09M |
Shareholders Equity | 47.11M | 79.03M | 78.38M | 64.79M | 68.3M | 72.4M | 63.42M | 68.12M | 72.67M | 70.45M | 73.34M | 78.95M | 82.85M | 86.55M | 92.22M | 120.71M | 124.71M | 117.67M |
Total Investments | n/a | 19K | 2.02M | 4.96M | 8.87M | 591K | 600K | 9.86M | 12.04M | 31.36M | 46.52M | 41.6M | 1.17M | 1.88M | 2.62M | 4.29M | 6.75M | 6.15M |